about
Novel compound heterozygous mutation in TREM2 found in a Turkish frontotemporal dementia-like familyPLA2G6 Mutations Related to Distinct Phenotypes: A New Case with Early-onset Parkinsonism.Exome sequencing reveals an unexpected genetic cause of disease: NOTCH3 mutation in a Turkish family with Alzheimer's diseaseUsing exome sequencing to reveal mutations in TREM2 presenting as a frontotemporal dementia-like syndrome without bone involvementLoss of VPS13C Function in Autosomal-Recessive Parkinsonism Causes Mitochondrial Dysfunction and Increases PINK1/Parkin-Dependent MitophagyEvaluation of incidence and clinical features of antibody-associated autoimmune encephalitis mimicking dementia.Mutation Frequency of the Major Frontotemporal Dementia Genes, MAPT, GRN and C9ORF72 in a Turkish Cohort of Dementia Patients.Identification of PSEN1 and PSEN2 gene mutations and variants in Turkish dementia patients.The Relationship of White Matter Hyperintensities with Depressive Symptoms and Daily Living Activities in Early-Stage Alzheimer's Disease Patients.Dementia and behavioral neurology: recent advances.Cognitive impairment and dementia in Parkinson's disease: practical issues and management.Comparison of Cognitive Parameters Between Bilateral and Unilateral Hippocampal Sclerosis.The prevalence of dementia in an urban Turkish population.The Association Between Clusterin and APOE Polymorphisms and Late-Onset Alzheimer Disease in a Turkish Cohort.The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer's disease, mild cognitive impairment or Parkinson's disease.Differentiating symptomatic Parkin mutations carriers from patients with idiopathic Parkinson's disease: contribution of automated segmentation neuroimaging method.Non-convulsive status epilepticus associated with glutamic acid decarboxylase antibody.BDNF, TNFα, HSP90, CFH, and IL-10 serum levels in patients with early or late onset Alzheimer's disease or mild cognitive impairment.Clozapine treatment in oromandibular dystonia.Interleukin-1alpha -889 C/T polymorphism in Turkish patients with late-onset Alzheimer's disease.Cognitive and anatomical correlates of anosognosia in amnestic mild cognitive impairment and early-stage Alzheimer's disease.An assessment of Movement Disorder Society Task Force diagnostic criteria for mild cognitive impairment in Parkinson's disease.Vitamin D deficiency might pose a greater risk for ApoEɛ4 non-carrier Alzheimer's disease patients.A novel homozygous DJ1 mutation causes parkinsonism and ALS in a Turkish family.Volumetric differences suggest involvement of cerebellum and brainstem in chronic migraine.Reduced orexin-A levels in frontotemporal dementia: possible association with sleep disturbance.Mutations in TYROBP are not a common cause of dementia in a Turkish cohort.The p.Thr11Met mutation in c19orf12 is frequent among adult Turkish patients with MPAN.Analysis of the tremor in juvenile myoclonic epilepsy.Achromatic temporal-frequency responses of human lateral geniculate nucleus and primary visual cortex.Expression changes of genes associated with apoptosis and survival processes in Parkinson's disease.FBXO7-R498X mutation: phenotypic variability from chorea to early onset parkinsonism within a family.Adult-onset phenylketonuria with rapidly progressive dementia and parkinsonism.First-episode psychotic disorder improving after immunotherapy.GC and VDR SNPs and Vitamin D Levels in Parkinson's Disease: The Relevance to Clinical Features.The distinct genetic pattern of ALS in Turkey and novel mutations.Erratum: Evaluation of OnabotulinumtoxinA Treatment in Patients with Concomitant Chronic Migraine and Temporomandibular DisordersPeripheral GRN mRNA and Serum Progranulin Levels as a Potential Indicator for Both the Presence of Splice Site Mutations and Individuals at Risk for Frontotemporal DementiaParkinson's Disease Dementia and Lewy Body DiseaseWhich cognitive dual-task walking causes most interference on the Timed Up and Go test in Parkinson's disease: a controlled study
P50
Q26996194-47393089-63D8-4C6C-9676-9D3CCA07C83BQ27300112-B28EBC3C-174E-49DC-8367-EED64E325175Q28254930-19706761-A73B-424E-9820-27D2DCDC642CQ28283330-20D1EF1B-3EF7-4B10-BEB4-32C383138013Q29147504-6008DD32-179E-4F64-A8AF-966E645DDF48Q33552523-ED60035B-E83E-4313-B0C0-8FF5F8D64BFBQ36134488-F723E96C-6C79-43C1-9538-2092496293A7Q36346551-E3ADD930-C97A-49E8-8E20-1C16075254C7Q37718110-29029F79-AD53-4B49-948A-AF628C4E09EBQ38004863-91A85B41-D0E0-4C67-8F83-1DD7D67DC2FEQ38206499-66A0C52D-DB18-4E86-93B0-9256F455E28EQ38378551-AEAEF282-0F85-4C59-818D-05C41C780CF8Q39834734-56B0A479-C193-425B-9DBE-C0B7E59D8B6DQ40801464-328F19C6-B2C0-4FC1-91AE-AF354FA3CD6FQ40907675-AD75A2DC-C0A0-42C4-920B-49FFDF846742Q42503984-DE58D388-A551-4DEC-B356-F3A7CD479F8DQ43981153-33BFA730-A3F6-4708-BB0C-50587D52D45BQ44592034-389006FE-89B6-405B-9AA8-E01623E1F447Q44977044-228CBA0B-922B-43AD-A4CE-A3B5921103C5Q45057738-AF931B97-2008-4A23-A8DC-DB1B9C8DAC0EQ46860885-8D7950D1-23EB-41D5-ADDD-3437FFA27327Q47615598-A1F26EC6-E554-45FA-9A43-1C9D18AF313AQ47992037-5064073A-BF5F-448B-B436-A196D28B76CBQ48061218-EB153200-EF00-4473-8EBE-B1D306C47E7AQ48163296-8965558F-6168-44C6-811F-4017125C0CEBQ48168473-55F6C828-1EEB-48C5-AE6A-28F5C955473FQ48191723-EA0CBFD7-F788-4DD8-A8C8-59F7FE02F929Q48243113-1A505397-7DE9-44CF-A611-A85104938EE9Q48433259-C4AED6ED-45F4-4A08-9E95-C1C028B53952Q48520562-F622F50B-72AB-4EFC-A13A-E7D95381B753Q48951225-774490B4-786B-41CE-A200-72C980BF6EF4Q50246862-0DE984A8-7E50-4F99-B1E0-116BB9E5DA12Q50538699-07FD2746-9B70-4FC4-9AB7-BB9C29697EA8Q50986233-B2A3887D-B6D1-4DAA-A031-A8EDE149696EQ51711360-BE462525-5A0F-4614-977D-D69ED1AC8A3EQ52967015-A4E7924E-94D7-4779-825B-CD3D1C61AF65Q64083064-154FC536-A41D-49C0-A62E-3E2B88894B3BQ64268616-4D419836-0D44-4218-BBBF-FFCA3F24ABEDQ64770116-1D6906CC-2C3D-4E53-9C2A-FFFAAFA485BDQ64859928-7534BFE7-3FD5-45F4-A9F5-9A138B46AFB6
P50
description
onderzoeker
@nl
researcher, ORCID id # 0000-0001-6032-0856
@en
name
Basar Bilgic
@ast
Basar Bilgic
@en
Basar Bilgic
@es
Basar Bilgic
@nl
type
label
Basar Bilgic
@ast
Basar Bilgic
@en
Basar Bilgic
@es
Basar Bilgic
@nl
prefLabel
Basar Bilgic
@ast
Basar Bilgic
@en
Basar Bilgic
@es
Basar Bilgic
@nl
P106
P31
P496
0000-0001-6032-0856